» Articles » PMID: 29563993

Flattening Filter-free Technique in Volumetric Modulated Arc Therapy for Lung Stereotactic Body Radiotherapy: A Clinical Comparison with the Flattening Filter Technique

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 Mar 23
PMID 29563993
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The present study sought to evaluate the impact of the flattening filter-free (FFF) technique in volumetric modulated arc therapy for lung stereotactic body radiotherapy. Its clinical safety and availability were compared with the flattening filter (FF) method. The cases of 65 patients who underwent lung volumetric modulated arc therapy-stereotactic body radiotherapy (VMAT-SBRT) using FF or FFF techniques were reviewed. A total of 55 Gy/4 fractions (fr) was prescribed for peripheral lesions or 56 Gy/7 fr for central lesions. The total monitor units (MU), treatment time, dose to tumors, dose to organs at risk, tumor control (local control rate, overall survival, progression-free survival) and adverse events between cases treated with FF and cases treated with the FFF technique were compared. A total of 35 patients were treated with conventional FF techniques prior to November 2014 and 30 patients were treated with FFF techniques after this date. It was revealed that the beam-on time was significantly shortened by the FFF technique (P<0.01). Other factors were similar for FFF and FF plans in respect to conformity (P=0.95), homogeneity (P=0.20) and other dosimetric values, including total MU and planning target volume/internal target volume coverage. The median follow-up period was 18 months (range, 2-35). One-year local control rates were 97.1 and 90.0% in the FF group and FFF groups, respectively (P=0.33). Grade 3 pneumonitis was observed in 5.8% of FF patients and 3.4% of FFF patients (P=1.00). No other adverse events ≥grade 3 were observed. The results of the study suggest that VMAT-SBRT using the FFF technique shortens the treatment time for lung SBRT while maintaining a high local control rate with low toxicity.

Citing Articles

Development of physical technology plays an important role in reducing radiation-induced lung injury.

Bai H, Bai J, Wang L, Liu X, Pan X, Li Q Chin Med J (Engl). 2024; 138(3):349-351.

PMID: 39682013 PMC: 11771720. DOI: 10.1097/CM9.0000000000003418.


Stereotactic body radiotherapy for early-stage lung cancer: a systematic review on the choice of photon energy and linac flattened/unflattened beams.

Gill A, Hirst A, Rowshanfarzad P, Gill S, Bucknell N, Dass J Radiat Oncol. 2024; 19(1):1.

PMID: 38167095 PMC: 10762943. DOI: 10.1186/s13014-023-02392-4.


Dosimetric verification of annual quality assurance for a linear accelerator using a transmission type detector.

Choi D, Kim J, Lee R, Ahn S, Ahn W Sci Rep. 2023; 13(1):17994.

PMID: 37865666 PMC: 10590446. DOI: 10.1038/s41598-023-45114-2.


Evaluation of flattening-filter-free and flattening filter dosimetric and radiobiological criteria for lung SBRT: A volume-based analysis.

Wu J, Song H, Li J, Tang B, Wu F Front Oncol. 2023; 13:1108142.

PMID: 36761961 PMC: 9903338. DOI: 10.3389/fonc.2023.1108142.


Impact of Dosimetric Parameters on Interplay Effects in 6 MV Flattening Filter-Free Photon Beams to Treat Lung Cancer.

Poolnapol V, Sanghangthum T, Keawsamur M J Med Phys. 2022; 47(1):20-26.

PMID: 35548034 PMC: 9084591. DOI: 10.4103/jmp.jmp_63_21.


References
1.
Niibe Y, Chang J . Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm Med. 2012; 2012:261096. PMC: 3432385. DOI: 10.1155/2012/261096. View

2.
Maquilan G, Timmerman R . Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer. Cancer J. 2016; 22(4):274-9. DOI: 10.1097/PPO.0000000000000204. View

3.
Takahashi W, Yamashita H, Kida S, Masutani Y, Sakumi A, Ohtomo K . Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2013; 86(3):426-31. DOI: 10.1016/j.ijrobp.2013.02.019. View

4.
Falkson C, Vella E, Yu E, El-Mallah M, MacKenzie R, Ellis P . Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review. Clin Lung Cancer. 2016; 18(2):105-121.e5. DOI: 10.1016/j.cllc.2016.10.008. View

5.
Nanda R, Liu Y, Gillespie T, Mikell J, Ramalingam S, Fernandez F . Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis. Cancer. 2015; 121(23):4222-30. DOI: 10.1002/cncr.29640. View